HeartRhythm

AUGUST 31, 2024

Conduction system pacing (CSP) has emerged as an alternative therapy to traditional right ventricular (RV) pacing. However, the majority of CSP studies reflect small cohorts or single-center experience.

Medicare 40

Medicare Heart Failure Hospital 40

Circulation

NOVEMBER 11, 2024

Background:Tricuspid regurgitation (TR) is a common occurrence in patients with heart failure (HF), and its role in disease progression has gained attention in recent years. Circulation, Volume 150, Issue Suppl_1 , Page A4142159-A4142159, November 12, 2024.

Heart Failure 40

Heart Failure Tricuspid Outcomes Medicare 40

American College of Cardiology

FEBRUARY 1, 2025

Initiatives such as the World Health Organization's "Medication Without Harm" and the Centers for Medicare and Medicaid Services' (CMS) expanded quality measures aim to reduce preventable emergency visits and hospital admissions due to medication-related harm. BMC Med2015;13(74). Page RL 2nd, O'Bryant CL, Cheng D, et al. Circulation.

Cardiovascular Disease 40

Cardiovascular Disease Coronary Artery Disease CMS Hospital 40

Vector Remote

MARCH 9, 2023

All About Cardiac Remote Patient Monitoring Software Comprehensive healthcare for rhythm, heart failure, and hypertension requires the ability to monitor a heart’s condition. With The Vector Patient Care Platform™ , patient connectivity and data management for rhythm, heart failure, and hypertension is simplified.

Heart Failure 52

Heart Failure Patient Care Heart Rhythm Hypertension 52

DAIC

JULY 25, 2024

FDA granted CardiAMP Cell Therapy a Breakthrough Device Designation for the treatment of ischemic heart failure. Leslie Miller, MD , trial investigator at the CHF Heart Function Clinic at BayCare Morton Plant Hospital in Clearwater, Florida and a member of the CardiAMP Heart Failure II Study Executive Steering Committee. “As

Heart Failure 111

Heart Failure Quality of Life CMS Reimbursement 111

DAIC

MARCH 13, 2024

CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. The CardiAMP Heart Failure II Trial is FDA approved to enroll up to 250 patients at up to 40 clinical centers. said Peter Altman , PhD.,

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

DAIC

MARCH 7, 2024

Results showed reductions in heart death equivalents and MACCE, with a magnified reduction among patients with elevated NTproBNP, a common marker of heart distress. These patients saw more than a 17% lower rate of heart death equivalents at up to two years compared to control patients treated with heart failure medication alone (2.9%

Heart Failure 105

Heart Failure Biomarkers Reimbursement CMS 105

DAIC

DECEMBER 8, 2023

The DRAIN-HF study will evaluate the Aortix percutaneous mechanical circulatory support (pMCS) technology in patients with acute decompensated heart failure (ADHF) who are unresponsive to standard medical therapy. I am excited to be able to include the advanced heart failure patients in the trial," commented Dr. Grafton.

Technology 113

Technology Heart Failure Heart Transplant Transplant 113

Journal of the American Heart Association

DECEMBER 24, 2024

BackgroundTranscatheter edgetoedge repair of the mitral valve (mTEER) reduced a hierarchical end point that included death and heart failure hospitalization in COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation Trial). days [0.07

Bicuspid/Mitral 45

Bicuspid/Mitral Heart Failure Medicare Inpatient 45

DAIC

MARCH 31, 2025

If left untreated, certain arrhythmias can damage the heart, brain, or other organs 4 and increase the risk of stroke or death. 3 billion per year, 8 while heart failure costs could reach $70 billion by 2030. Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association.

Arrhythmia 52

Arrhythmia Atrial Fibrillation Tachycardia Heart Failure 52

DAIC

APRIL 24, 2024

partially because its key risk factor, high blood pressure, is a ‘silent killer,’ and most patients have no symptoms before their first heart attack or stroke. CVD is especially prevalent in the Medicare-aged population, affecting more than 75 percent of those aged 60-79 and more than 90 percent of those aged 80 and over.

Blood Pressure 116

Blood Pressure Cholesterol Technology Heart attacks 116

Circulation: Heart Failure

JANUARY 26, 2024

Circulation: Heart Failure, Ahead of Print. Patients who underwent bariatric surgery were matched to controls in a 1:2 ratio (matched on exact age, sex, race, body mass index, HF encounter year, and HF hospitalization rate pre-surgery/matched period).

Heart Failure 40

Heart Failure Obesity Outcomes Medicare 40

Journal of the American Heart Association

MARCH 21, 2025

However, the association of socioeconomic vulnerability and outcomes after hospitalization is uncertain.Methods and ResultsAmerican Heart Association COVID19 Cardiovascular Disease Registry hospitalizations between March 1, 2020, and June 30, 2022, linked with Medicare feeforservice claims, were analyzed.

COVID-19 40

COVID-19 Medicare Cardiogenic Shock Hospital 40

Journal of the American Heart Association

FEBRUARY 16, 2024

BackgroundIn the EMPEROR‐Reduced trial (Empagliflozin Outcome Trial in Patients with Chronic Heart Failure and a Reduced Ejection Fraction), empagliflozin plus standard of care reduced the composite of cardiovascular death or hospitalization for heart failure versus standard of care in adults with heart failure with reduced ejection fraction.

Heart Failure 40

Heart Failure Medicare Hospital Cardiomyopathy 40

Cardiomatics

FEBRUARY 9, 2022

One of these diseases is heart failure – a condition in which the heart is unable to pump enough blood to the organs in our body. Unfortunately, the number of patients with heart failure continues to grow. Of course, there is drug treatment for heart failure, but it is not always sufficient.

Heart Failure 52

Heart Failure Myocardial Infarction Medicare Defibrillator 52

Stroke Journal

JANUARY 30, 2025

A logistic regression model was adjusted for age, sex, race, mechanical ventilation, systolic blood pressure, smoking status, diabetes mellitus, atrial fibrillation, hypertension, congestive heart failure, Glasgow Coma Scale, ICH location (side and deep), ICH volume on CT, and presence of intraventricular hemorrhage. 1.84, p=0.009).Conclusion:Amongst

Hemorrhage 40

Hemorrhage Medicare Outcomes Medicaid 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Study Population includes all patients with an ischemic stroke inpatient admission in 2018 and were continuously enrolled with Medicare FFS for 1 year prior to and following their initial 2018 stroke admission. 1.378]), and heart failure (1.282 [95%CI, 1.25‐1.315]).ConclusionPatient 1.378]), and heart failure (1.282 [95%CI, 1.25‐1.315]).ConclusionPatient

Risk Factors 40

Risk Factors Strokes Stroke Medicare 40

Circulation

JANUARY 23, 2024

BACKGROUND:Guideline-directed medical therapies (GDMTs) are the mainstay of treatment for heart failure with reduced ejection fraction (HFrEF), but they are underused. 0.76]) compared with Medicare (HR, 0.85 [95% CI, 0.77–0.92]);Pinteractionsex×insurance Circulation, Ahead of Print.

Heart Failure 45

Heart Failure Medicare Circulation Outcomes 45

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Circulation

NOVEMBER 11, 2024

The aim of this study is to examine the risks of adverse outcomes following CA in older people with AF.Methods:Using 2014-2019 Medicare claims, we conducted a propensity score analysis of patients treated with CA within 6 months of new AF diagnosis to patients treated with only antiarrhythmic therapy in the 6-month period.

Atrial Fibrillation 40

Atrial Fibrillation Medicare Ablation Outcomes 40

Frontiers in Cardiovascular Medicine

NOVEMBER 24, 2024

Demographics, visit data, and outcomes were collected, and 30-day outcomes were compared to inpatient IV (IP IV) diuresis from 2021 Medicare HF hospitalizations.ResultsThe review included 1,590 unique patients treated with OP IV diuretics, with a mean age of 70 ± 6 years, 69.7% male, and 74.8% NYHA III-IV. respectively).

Outpatient 59

Outpatient Heart Failure Medicare Inpatient 59